. Lessons learned from a progressive supranuclear palsy trial. Lancet Neurol. 2021 Mar;20(3):162-163. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. Tilavonemab